Peyronie’s disease: an update of the medical management

Bibliography

• GRIEF LC: Peyronie's disease. The role of radiation therapy and a general review. Am. j Roentgenol Radium. Ther: Nucl. Med. (1967) 100(4):916–919.
   PubMedGoogle Scholar
• MCROBERTS JW: Peyronie's Disease. Cynecol Obstet. (1969) 129(6):1291–1294.
   Google Scholar
• BILLIG R, BAKER R, IMMERGUT M, MAXTED W: Peyronie's disease.Urology (1975) 6(4):409–418.
   PubMedGoogle Scholar
• KADIOGLU A, TEFEKLI A, EROL B: A retrospective review of 307 men with peyronie's disease. Urol. (2002) 168:1075–1079.
   Google Scholar
• HAKIM LS: Peyronie's disease: an update - the role of diagnostics. Int. J. Impot. Res. (2002) 14:321–323.
   PubMedGoogle Scholar
• LINDSAY M, SCHAIN D, GRAMBSCH P et al: The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J. Urol. (1991) 146:1007–1009.
   PubMed Web of Science ®Google Scholar
• SOMMER F, SCHWARZER U, WASSMER G et al.: Epidemiology of Peyronie's disease. Int J. Impot. Res. (2002) 14(5):379–383.
   PubMedGoogle Scholar
• •A thorough review of epidemiological data on PD.
   Google Scholar
• RHODEN EL, TELOKEN C, TING HY et al.: Prevalence of Peyronie's disease in men over 50 years old from Southern Brazil. Int. J. Impot. Res. (2001) 13(5):291–293.
   PubMedGoogle Scholar
• GHOLAMI SS, LUE TF: Peyronie's disease. Urol. Clin. North Am. (2001) 28(2):377–390.
   PubMedGoogle Scholar
• SMITH BH: Subclinical Peyronie's disease. Am. J. Clin. Pathol (1969) 52:385–390.
   PubMed Web of Science ®Google Scholar
• HELLSTROM WJ, BIVALACQUA TJ: Peyronie's disease: etiology, medical and surgical therapy. Andra (2000) 21(3):347–354.
   PubMed Web of Science ®Google Scholar
• •A comprehensive review article.
   Google Scholar
• CHILTON CP, CASTLE WM, WESTWOOD CA et al: Factors associated in the aetiology of Peyronie's disease. Br: J. Urol. (1982) 54:748–750.
   PubMedGoogle Scholar
• DEVINE CJ, HORTON CE: Peyronie's disease. Clin. Plast. Surg. (1988) 15:405–409.
   PubMedGoogle Scholar
• JAROW JP, LOWE FC: Penile trauma: an etiological factor in Peyronie's disease and erectile dysfunction. J. Urol. (1997) 158:1388.
   PubMed Web of Science ®Google Scholar
• LEVINE LA, MERRICK PF, LEE RC: Intralesional verapamil injection for the treatment of Peyronie's disease. j Urol. (1994) 151:1522–1524.
   PubMed Web of Science ®Google Scholar
• EL-SAKKA Al, SELPH CA, YEN TS et al: The effect of surgical trauma on rat tunica albuginea. Urol. (1998) 159:1700–1707
   Google Scholar
• LUE TF: Peyronie's disease: an anatomically based hypothesis and beyond. Int J. Impot. Res. (2002) 14:411–413.
   PubMed Web of Science ®Google Scholar
• BORDER W, NOBLE N: Transforming growth factor in tissue fibrosis. N Engl. Med(1994) 331:1286–1291.
   PubMed Web of Science ®Google Scholar
• EL-SAKKA Al, HASSAN MU, NUNES L et al.: Histological and ultrastructural alterations in an animal model of Peyronie's disease. Br: J. Urol. (1998) 81:445–452.
   PubMedGoogle Scholar
• EL-SAKKA Al, HASSOBA H, PILLARISETTY RI et al: Peyronie's disease is associated with an increase in transforming growth factor 13 protein expression. J. Urol. (1997) 158(4):1391–1394.
   PubMed Web of Science ®Google Scholar
• NOSS MB, DAY NS, CHRIST GJ etal.: The genetics and immunology of Peyronie's disease. Int J. Impot. Res. (2000) 12(4):S127–5132.
   Google Scholar
• RALPH DJ, MIRAKIAN R, PRYOR JP etal.: The immunological features of Peyronie's disease. J. Urol. (1996) 155:159–162.
   Google Scholar
• YUDKIN JS: Peyronie's disease and its association with metoprolol. Lancet (1977) 2:1355.
   PubMedGoogle Scholar
• BIVALACQUA TJ, PUROHIT SK, HELLSTROM WJ: Peyronie's disease: advances in basic science and Pathophysiology. Curr. Urol. Rep. (2000) 1(4):297–301.
   PubMedGoogle Scholar
• CARSON CC: Peyronie's disease: newer diagnostic studies and surgical alternatives. Carr. Opin. Urol. (1994) 4(3):180–185.
   Google Scholar
• LYKES K, GOLD D, NEWTON R et al: Peyronie's disease is associated with Paget's disease of the bone. Bone Min. Res. (1997) 12:929–934.
   Google Scholar
• NYBERG LM Jr, BIAS WB, HOCHBERG MC et al.: Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatability B7 cross-reacting antigens...! Urol. (1982) 128:48–51
   Google Scholar
• EL-SAKKA Al, LUE TF: Peyronie's disease. Carr. Opinion. Urol. (1998) 8:203–209.
   PubMedGoogle Scholar
• ••A balanced overall review.
   Google Scholar
• PHELAN MJ, RIPLEY PL, LYNCH MP: Methotrexate associated Peyronie's disease in the treatment of rheumatoid arthiritis. Br. J. Rheumatol (1992) 31:425–426.
   PubMedGoogle Scholar
• PRYOR JP, RALPH DJ: Clinical presentations of Peyronie's disease. Intl Impot. Res. (2002) 14:414–417.
   PubMed Web of Science ®Google Scholar
• GELBARD MK, DOREY F, JAMES K: The natural history of Peyronie's disease. Urol. (1990) 144:1376–1380.
   Google Scholar
• DEVINE CJ Jr, SOMERS KD, JORDAN SG etal.: Proposal: trauma as the cause of Peyronie's lesion. Urol. (1997) 157:285–290.
   Google Scholar
• GHOLAMI SS, GONZALEZ-CADAVID NF, LIN C et al: Peyronie's disease: a review. J. Urol. (2003) 169(4):1234–1241.
   PubMedGoogle Scholar
• ••A well structured and referenced article.
   Google Scholar
• MORELAND RB, NEHRA A: Pathophysiology of Peyronie's disease. Intl Impot. Res (2002) 14:406–410.
   PubMed Web of Science ®Google Scholar
• •Good for molecular basis of PD.
   Google Scholar
• LOPEZ JA, JAROW JP: Penile vascular evaluation of men with Peyronie's disease. I Urol. (1993) 149(1):53–55.
   PubMed Web of Science ®Google Scholar
• GASIOR BL, LEVINE FJ, HOWANNESIAN A, KRANE RJ, GOLDSTEIN I: Plaque-associated corporal veno-occlusive dysfunction in idiopathic Peyronie's disease, a pharmacocavernosometric and pharmacocavernosographic study. World J. Urol. (1990) 8:90–96.
   Google Scholar
• ORD J, CRANSTON D: Urology update - common conditions. Int. I. STD AIDS (2002) 13(9):640–644
   PubMedGoogle Scholar
• WESSON MB: Peyronie's disease (plastic induration): cause and treatment. Urol. (1943) 49:350.
   Google Scholar
• MYNDERSE LA, MONGA M: Oral therapy for Peyronie's disease. Int. .1. Impot. Res. (2002) 14:340–344.
   PubMed Web of Science ®Google Scholar
• HASCHE-KLUNDER R: Treatment of Peyronie's disease using para-aminobenzoate (Potaba). Urologe A. (1978) 17:224–227.
   PubMedGoogle Scholar
• CARSON C: Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective? Tech. Urol. (1997) 3:135–139.
   Google Scholar
• BIAGIOTTI G, CAVALLINI G: Acetyl-L-carnitine versus tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. Br J. Urol. Int. (2001) 88(1):63–67.
   Google Scholar
• RALPH DJ, BROOKS MD, BOTTAZO GF et al.: The treatment of Peyronie's disease with tamoxifen. Br J. Urol. (1992) 70:648–651.
   PubMedGoogle Scholar
• LISCHER GH, NEHRA A: New advances in Peyronie's disease. Carr. Opinion Urol. (2001) 11(6):631–636.
   PubMedGoogle Scholar
• •A comprehensive review.
   Google Scholar
• TELOKEN C, RHODEN EL, GRAZZIOTIN TM et al.: Tamoxifen versus placebo in the treatment of Peyronie's disease. Urol. (1999) 162:2003–2005.
   Google Scholar
• AKKUS E, CARRIERS, REHMAN J et al.: Is colchicines effective in Peyronie's disease? A pilot study. Urology (1994) 44:291–295.
   PubMedGoogle Scholar
• BYSTROM J: Induration penis plasitca. Experience of treatment with procarbazine Natulan. Scand. Urol. Nephrol (1976) 10(1):21–25.
   PubMed Web of Science ®Google Scholar
• SCHROEDER-PRINTZEN I, HAUCK EW, WEIDNER W: New aspects in Peyronie's disease - a mini review. Andrologia (1999) 31 (Suppl. 1):31–35.
   Google Scholar
• GELBARD MK, JAMES N, RIACH P et al.: Collagenase versus placebo in the treatment of Peyronie's disease: a double blind study. Urol. (1993) 149:56–58.
   Google Scholar
• LACY GL, ADAMS DM, HELLSTROM WJG: Intralesional interferon-alpha-2b for the treatment of Peyronie's disease. Int. j Impot. Res. (2002) 14:336–339.
   PubMed Web of Science ®Google Scholar
• DUNCAN MR, BERMAN B, NSEYO UO: Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons alpha, beta, and gamma. Scand. Urol. Nephrol (1991) 25:89–94.
   PubMed Web of Science ®Google Scholar
• AHUJA S, BIVALAQUA T, CASE J et al:A pilot study demonstrating clinical benefit from intralesional interferon alpha 2b in the treatment of Peyronie's disease. J. Andra (1999) 20:444–448.
   PubMedGoogle Scholar
• JUDGE IS, WIDNIEWSKI ZS: Intralesional interferon in the treatment of Peyronie's disease: a pilot study. Br J. Urol. (1997) 79:40–42.
   PubMedGoogle Scholar
• LEVINE LA, DESTRADA CR: Review: intralesional verapamil for the treatment of Peyronie's disease. Int. .1. Impot. Res. (2002) 14:324–328.
   Google Scholar
• LEVINE LA: Advances in the medical therapy of Peyronie's disease. Int. .1. Impot. Res. (1998) 10:123–124.
   PubMedGoogle Scholar
• REHMAN J, BENET A, MELMAN A: Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long term single blind study. Urology (1998) 51:620–626.
   PubMed Web of Science ®Google Scholar
• MCCAHY PJ, TAYAL SC: Peyronie's disease. Intl STD AIDS (1997) 8:141–144.
   PubMedGoogle Scholar
• HAUCK EW, WEIDNER W: Francois de la Peyronie and the disease named after him. Lancet (2001) 357:2049–2051.
   PubMedGoogle Scholar
• NATALE S, ASHDOWN J, MCLARTY E et al.: An evaluation of a new treatment for Peyronie's disease using ESWL [abstract]. Br J. Urol. Int. (1999) 83 (Suppl. 4):A153:56.
   Google Scholar
• HUSAIN J, LYNN NN, JONES DK et al.: Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience. Br J. Urol. Int. (2000) 86(4):466–468.
   Google Scholar
• MONTORSI F, SALONIA A. GUAZZONI G et al.: Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results. J. Andra (2000) 21:85–90.
   Google Scholar
• RIEDL CR, PLAS E, VORAUER K et a/.: Pilot study on liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease. Ear: Urol. (2001) 40:343–349.
   Google Scholar
• BIVALACQUA TJ, PURHIT S, SRESTHDATTA A et al.: Potential role of nuclear-kB in the induction of Peyronie's-like condition in the rat. J. Urol. (1999) 161:781A.
   Google Scholar